Discontinuation report CODEINE PHOSPHATE INJECTION USP
Report ID | 159064 |
Drug Identification Number | 00544884 |
Brand name | CODEINE PHOSPHATE INJECTION USP |
Common or Proper name | CODEINE PHOSPHATE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CODEINE PHOSPHATE |
Strength(s) | 30MG |
Dosage form(s) | LIQUID |
Route of administration | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR |
Packaging size | 1ML 10LIAM |
ATC code | R05DA |
ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-04-20 |
Remaining supply date | 2022-04-20 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-04-20 | French | Compare |
v1 | 2022-04-20 | English | Compare |
Showing 1 to 2 of 2